Monday, March 30, 2020

USFDA classifies Sun Pharma#39;s Halol manufacturing site for official action, may put all new approvals on hold

USFDA classifies Sun Pharma#39;s Halol manufacturing site for official action, may put all new approvals on hold The OAI status implies that the USFDA may put all new approvals from the Halol facility on hold till the outstanding corrective actions are completed.

from Moneycontrol Business News https://ift.tt/3artekw

No comments:

Post a Comment

Vikas Khemani on key triggers that will shape the market’s next big move

Most people kind of turned bearish on global concerns, oil prices. So, people tend to kind of extrapolate more bad news. So that has happene...